Daniel W. Nebert | Academic Influence

Daniel W. Nebert's AcademicInfluence.com Rankings

Daniel W. Nebert

Medical

#404

World Rank

#563

Historical Rank

#168

USA Rank

Pharmacology

#33

World Rank

#42

Historical Rank

#14

USA Rank

medical Degrees

Daniel W. Nebert

Philosophy

#2266

World Rank

#3914

Historical Rank

#833

USA Rank

Logic

#508

World Rank

#933

Historical Rank

#203

USA Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Daniel W. Nebert's Degrees

Doctorate Medicine University of Cincinnati
PhD Pharmacology University of Cincinnati

Why Is Daniel W. Nebert Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Daniel Walter Nebert is an American physician-scientist. He is a professor emeritus at the University of Cincinnati College of Medicine. His research has revolved around the central theme of gene–environment interaction.

(See a Problem?)

Daniel W. Nebert's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. (1996) (2884)
P450 genes: structure, evolution, and regulation. (1987) (1576)
Substrate-inducible microsomal aryl hydroxylase in mammalian cell culture. I. Assay and properties of induced enzyme. (1968) (1534)
Clinical importance of the cytochromes P450 (2002) (1344)
Role of Aryl Hydrocarbon Receptor-mediated Induction of the CYP1 Enzymes in Environmental Toxicity and Cancer* (2004) (1114)
The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. (1997) (1089)
The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature. (1991) (1056)
Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. (2004) (999)
Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. (2000) (973)
The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis (2006) (834)
Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. (2005) (827)
The P450 gene superfamily: recommended nomenclature. (1987) (774)
Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents (1989) (721)
Characterization of the common genetic defect in humans deficient in debrisoquine metabolism (1988) (714)
Human ATP-binding cassette (ABC) transporter family (2009) (619)
Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis. (1982) (565)
The P450 superfamily: updated listing of all genes and recommended nomenclature for the chromosomal loci. (1989) (552)
Evolution of the P450 gene superfamily: animal-plant 'warfare', molecular drive and human genetic differences in drug oxidation. (1990) (505)
The Ah locus: genetic differences in toxicity, cancer, mutation, and birth defects. (1989) (462)
Role of the Ah Receptor and the Dioxin‐Inducible [Ah] Gene Battery in Toxicity, Cancer, and Signal Transduction a (1993) (454)
The in vivo and in vitro induction of aryl hydrocarbon hydroxylase in mammalian cells of different species, tissues, strains, and developmental and hormonal states. (1969) (412)
Nomenclature for human CYP2D6 alleles. (1996) (409)
Human cytochromes P450 in health and disease (2013) (392)
Regulatory gene product of the Ah locus. Characterization of the cytosolic inducer-receptor complex and evidence for its nuclear translocation. (1979) (352)
Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer. (1996) (335)
Analysis and update of the human aldehyde dehydrogenase (ALDH) gene family (2005) (334)
Analysis and update of the human solute carrier (SLC) gene superfamily (2009) (326)
Feedback Control of AHR Signaling Regulates Intestinal Immunity (2017) (319)
Oral exposure to benzo[a]pyrene in the mouse: detoxication by inducible cytochrome P450 is more important than metabolic activation. (2004) (316)
ZIP8, Member of the Solute-Carrier-39 (SLC39) Metal-Transporter Family: Characterization of Transporter Properties (2006) (309)
Analysis of the glutathione S-transferase (GST) gene family (2004) (301)
Slc39a14 Gene Encodes ZIP14, A Metal/Bicarbonate Symporter: Similarities to the ZIP8 Transporter (2008) (296)
Evolutionary divergence and functions of the human interleukin (IL) gene family (2010) (290)
Genetic expression of aryl hydrocarbon hydroxylase activity. Induction of monooxygenase activities and cytochrome P1-450 formation by 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice genetically "nonresponsive" to other aromatic hydrocarbons. (1974) (281)
The vascular system as a target of metal toxicity. (2008) (275)
Proposed role of drug-metabolizing enzymes: regulation of steady state levels of the ligands that effect growth, homeostasis, differentiation, and neuroendocrine functions. (1991) (274)
Update on the aldehyde dehydrogenase gene (ALDH) superfamily (2011) (272)
Identification of mouse SLC39A8 as the transporter responsible for cadmium-induced toxicity in the testis. (2005) (265)
Genetic mechanisms controlling the induction of polysubstrate monooxygenase (P-450) activities. (1981) (262)
The UDP glucuronosyltransferase gene superfamily: suggested nomenclature based on evolutionary divergence. (1991) (257)
Genetically altered mice to evaluate glutathione homeostasis in health and disease. (2004) (256)
Role of genetics and drug metabolism in human cancer risk. (1991) (252)
Initial Characterization of the Glutamate-Cysteine Ligase Modifier Subunit Gclm(−/−) Knockout Mouse (2002) (247)
ZIP8 regulates host defense through zinc-mediated inhibition of NF-κB. (2013) (245)
Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist? (1999) (242)
The chemical defensome: environmental sensing and response genes in the Strongylocentrotus purpuratus genome. (2006) (235)
Genetic expression of aryl hydrocarbon hydroxylase activity in the mouse (1975) (232)
Oral Benzo[a]pyrene in Cyp1 Knockout Mouse Lines: CYP1A1 Important in Detoxication, CYP1B1 Metabolism Required for Immune Damage Independent of Total-Body Burden and Clearance Rate (2006) (225)
Knockout of the mouse glutamate cysteine ligase catalytic subunit (Gclc) gene: embryonic lethal when homozygous, and proposed model for moderate glutathione deficiency when heterozygous. (2000) (221)
Genetic regulation of aryl hydrocarbon hydroxylase induction. II. Simple Mendelian expression in mouse tissues in vivo. (1972) (218)
Eukaryotic aldehyde dehydrogenase (ALDH) genes: human polymorphisms, and recommended nomenclature based on divergent evolution and chromosomal mapping. (1999) (216)
Human dioxin-inducible cytochrome P1-450: complementary DNA and amino acid sequence. (1985) (215)
SLC39A8 Deficiency: A Disorder of Manganese Transport and Glycosylation. (2015) (214)
Substrate-inducible microsomal aryl hydroxylase in mammalian cell culture. II. Cellular responses during enzyme induction. (1968) (210)
Aryl hydrocarbon hydroxylase induction by polycyclic hydrocarbons: simple autosomal dominant trait in the mouse. (1972) (206)
Drug-metabolizing enzymes in ligand-modulated transcription. (1994) (206)
Temperature-dependent cytosol-to-nucleus translocation of the Ah receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in continuous cell culture lines. (1980) (205)
Cellular responses to oxidative stress: the [Ah] gene battery as a paradigm. (1990) (204)
Update of human and mouse forkhead box (FOX) gene families (2010) (202)
The Ah locus and the metabolism of chemical carcinogens and other foreign compounds. (1977) (200)
Trout P450IA1: cDNA and deduced protein sequence, expression in liver, and evolutionary significance. (1988) (200)
NAD(P)H:quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: A HuGE review (2002) (198)
Human CYP1A1 gene: cosegregation of the enzyme inducibility phenotype and an RFLP. (1991) (197)
Dioxin induces expression of c-fos and c-jun proto-oncogenes and a large increase in transcription factor AP-1. (1992) (193)
Aryl hydrocarbon hydroxylase activity in human placenta from cigarette smoking and nonsmoking women. (1969) (180)
Evolution of the cytochrome P450 genes. (1989) (178)
Update of the human and mouse SERPIN gene superfamily (2013) (177)
Tissue-specific expression of the mouse dioxin-inducible P(1)450 and P(3)450 genes: differential transcriptional activation and mRNA stability in liver and extrahepatic tissues (1986) (176)
Glutathione defense mechanism in liver injury: insights from animal models. (2013) (175)
Human dioxin-inducible cytosolic NAD(P)H:menadione oxidoreductase. cDNA sequence and localization of gene to chromosome 16. (1988) (175)
Genetic expression of aryl hydrocarbon hydroxylase induction. IV. Interaction of various compounds with different forms of cytochrome P-450 and the effect on benzo(a)pyrene metabolism in vitro. (1972) (168)
Dioxin causes a sustained oxidative stress response in the mouse. (1998) (166)
Mitochondrial aldehyde dehydrogenase-2 (ALDH2) Glu504Lys polymorphism contributes to the variation in efficacy of sublingual nitroglycerin. (2006) (165)
Update of the NAD(P)H:quinone oxidoreductase (NQO) gene family (2006) (165)
The murine Ah locus: in utero toxicity and teratogenesis associated with genetic differences in benzo[a]pyrene metabolism. (1979) (164)
Human debrisoquine 4-hydroxylase (P450IID1): cDNA and deduced amino acid sequence and assignment of the CYP2D locus to chromosome 22. (1988) (160)
The aryl hydrocarbon receptor functions as a tumor suppressor of liver carcinogenesis. (2010) (159)
Cyp1a2(-/-) null mutant mice develop normally but show deficient drug metabolism. (1996) (156)
The murine Ah locus. Comparison of the complete cytochrome P1-450 and P3-450 cDNA nucleotide and amino acid sequences. (1984) (156)
Dioxin-dependent activation of murine Cyp1a-1 gene transcription requires protein kinase C-dependent phosphorylation (1992) (155)
Mitochondrial reactive oxygen production is dependent on the aromatic hydrocarbon receptor. (2002) (154)
Ontogenetic expression of polycyclic aromatic compound-inducible monooxygenase activities and forms of cytochrome P-450 in rabbit. Evidence for temporal control and organ specificity of two genetic regulatory systems. (1977) (153)
Endogenous Functions of the Aryl Hydrocarbon Receptor (AHR): Intersection of Cytochrome P450 1 (CYP1)-metabolized Eicosanoids and AHR Biology* (2008) (153)
Complete cDNA and protein sequence of a pregnenolone 16 alpha-carbonitrile-induced cytochrome P-450. A representative of a new gene family. (1985) (153)
Revised nomenclature for the mammalian long-chain acyl-CoA synthetase gene family Published, JLR Papers in Press, August 1, 2004. DOI 10.1194/jlr.E400002-JLR200 (2004) (152)
The Ah locus: Correlation of intranuclear appearance of inducer-receptor complex with induction of cytochrome P1-450 mRNA (1982) (149)
Update on the olfactory receptor (OR) gene superfamily (2008) (148)
Regulatory gene product of the Ah locus. Characterization of receptor mutants among mouse hepatoma clones. (1982) (148)
Aryl hydrocarbon receptor (AHR): "pioneer member" of the basic-helix/loop/helix per-Arnt-sim (bHLH/PAS) family of "sensors" of foreign and endogenous signals. (2017) (147)
Regulation of the mammalian cytochrome P1-450 (CYP1A1) gene. (1989) (146)
Autosomal-Recessive Intellectual Disability with Cerebellar Atrophy Syndrome Caused by Mutation of the Manganese and Zinc Transporter Gene SLC39A8. (2015) (146)
Human CYP1A2: sequence, gene structure, comparison with the mouse and rat orthologous gene, and differences in liver 1A2 mRNA expression. (1989) (145)
Structural gene products of the Ah locus. Transcriptional regulation of cytochrome P1-450 and P3-450 mRNA levels by 3-methylcholanthrene. (1984) (142)
Debrisoquine 4-hydroxylase: characterization of a new P450 gene subfamily, regulation, chromosomal mapping, and molecular analysis of the DA rat polymorphism. (1987) (140)
Cd2+ versus Zn2+ uptake by the ZIP8 HCO3--dependent symporter: kinetics, electrogenicity and trafficking. (2008) (139)
Human P1-450 gene sequence and correlation of mRNA with genetic differences in benzo[a]pyrene metabolism. (1985) (139)
Genetic control of interindividual variations in the inducibility of aryl hydrocarbon hydroxylase in cultured human lymphocytes. (1976) (138)
Glutathione Redox State Regulates Mitochondrial Reactive Oxygen Production* (2005) (137)
Autoregulation plus upstream positive and negative control regions associated with transcriptional activation of the mouse P1(450) gene. (1985) (137)
The Evolution of Drug Metabolism (2000) (137)
Polymorphisms in drug-metabolizing enzymes: what is their clinical relevance and why do they exist? (1997) (134)
Update of the human and mouse Fanconi anemia genes (2015) (132)
Isolation and sequence of cDNA encoding a cytochrome P-450 from an insecticide-resistant strain of the house fly, Musca domestica. (1989) (130)
Structural gene products of the Ah locus. Genetic and immunochemical evidence for two forms of mouse liver cytochrome P-450 induced by 3-methylcholanthrene. (1979) (130)
Sulfobetaine derivatives of bile acids: nondenaturing surfactants for membrane biochemistry. (1983) (126)
Aldehyde dehydrogenase (ALDH) superfamily in plants: gene nomenclature and comparative genomics (2012) (126)
Glutamate Cysteine Ligase Catalysis (2005) (123)
Multiple forms of cytochrome P-450 and the importance of molecular biology and evolution. (1982) (122)
Genetic epidemiology of environmental toxicity and cancer susceptibility: human allelic polymorphisms in drug-metabolizing enzyme genes, their functional importance, and nomenclature issues. (1999) (119)
Targeted knockout of Cyp1a1 gene does not alter hepatic constitutive expression of other genes in the mouse [Ah] battery. (2000) (118)
Dioxin exposure is an environmental risk factor for ischemic heart disease (2007) (118)
Cyp1a1(-/-) male mice: protection against high-dose TCDD-induced lethality and wasting syndrome, and resistance to intrahepatocyte lipid accumulation and uroporphyria. (2004) (117)
Dioxin increases reactive oxygen production in mouse liver mitochondria. (2002) (117)
Oral Benzo[a]pyrene: Understanding Pharmacokinetics, Detoxication, and Consequences—Cyp1 Knockout Mouse Lines as a Paradigm (2013) (116)
Human AH locus polymorphism and cancer: inducibility of CYP1A1 and other genes by combustion products and dioxin. (1991) (115)
Benzo[a]pyrene-induced toxicity: paradoxical protection in Cyp1a1(-/-) knockout mice having increased hepatic BaP-DNA adduct levels. (2001) (113)
Discovery of ZIP transporters that participate in cadmium damage to testis and kidney. (2009) (113)
Hepatocyte‐specific Gclc deletion leads to rapid onset of steatosis with mitochondrial injury and liver failure (2007) (113)
Regulation of mouse CYP1A1 gene expression by dioxin: requirement of two cis-acting elements during induction (1989) (112)
Tissue- and cell type-specific expression of cytochrome P450 1A1 and cytochrome P450 1A2 mRNA in the mouse localized in situ hybridization. (1999) (111)
COVID-19 vulnerability: the potential impact of genetic susceptibility and airborne transmission (2020) (110)
Transgenic Zebrafish as Sentinels for Aquatic Pollution (2000) (110)
Enhanced cadmium-induced testicular necrosis and renal proximal tubule damage caused by gene-dose increase in a Slc39a8-transgenic mouse line. (2007) (109)
Extreme discordant phenotype methodology: an intuitive approach to clinical pharmacogenetics. (2000) (108)
From Human Genetics and Genomics to Pharmacogenetics and Pharmacogenomics: Past Lessons, Future Directions (2008) (106)
The Ah regulatory gene product. Survey of nineteen polycyclic aromatic compounds' and fifteen benzo[a]pyrene metabolites' capacity to bind to the cytosolic receptor. (1982) (104)
Smoke carcinogens cause bone loss through the aryl hydrocarbon receptor and induction of Cyp1 enzymes (2013) (103)
Ten nucleotide differences, five of which cause amino acid changes, are associated with the Ah receptor locus polymorphism of C57BL/6 and DBA/2 mice. (1993) (101)
Glutamate-cysteine ligase modifier subunit: mouse Gclm gene structure and regulation by agents that cause oxidative stress. (2002) (100)
Differential metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in mice humanized for CYP1A1 and CYP1A2. (2005) (100)
Mutations affecting the regulation of transcription of the cytochrome P1-450 gene in the mouse Hepa-1 cell line. (1985) (100)
Aryl hydrocarbon hydroxylase induction in mammalian liver-derived cell cultures. Stimulation of "cytochrome P1-450-associated" enzyme activity by many inducing compounds. (1975) (99)
Search for an association between the human CYP1A2 genotype and CYP1A2 metabolic phenotype (2006) (98)
The Ah locus, a multigene family necessary for survival in a chemically adverse environment: comparison with the immune system. (1982) (96)
ZIP8 Zinc Transporter: Indispensable Role for Both Multiple-Organ Organogenesis and Hematopoiesis In Utero (2012) (94)
Mouse cytosolic class 3 aldehyde dehydrogenase (Aldh3a1): gene structure and regulation of constitutive and dioxin-inducible expression. (1999) (94)
Purification and characterization of heterologously expressed mouse CYP2A5 and CYP2G1: role in metabolic activation of acetaminophen and 2,6-dichlorobenzonitrile in mouse olfactory mucosal microsomes. (1998) (92)
Transcription factors and cancer: an overview. (2002) (91)
Advances in pharmacogenomics and individualized drug therapy: exciting challenges that lie ahead. (2004) (90)
Role of CYP1A2 in the hepatotoxicity of acetaminophen: investigations using Cyp1a2 null mice. (1998) (90)
Protection of the Cyp1a2(-/-) null mouse against uroporphyria and hepatic injury following exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. (2001) (89)
Genetic expression of aryl hydrocarbon hydroxylase induction. Evidence for the involvement of other genetic loci. (1974) (88)
Evolutionary divergence and functions of the ADAM and ADAMTS gene families (2009) (88)
Update of human and mouse matrix metalloproteinase families (2010) (85)
Suggestions for the nomenclature of human alleles: relevance to ecogenetics, pharmacogenetics and molecular epidemiology. (2000) (85)
Toward the evaluation of function in genetic variability: Characterizing human SNP frequencies and establishing BAC‐transgenic mice carrying the human CYP1A1_CYP1A2 locus (2005) (85)
Genetic differences in microsomal electron transport: the Ah locus. (1978) (84)
Genetic differences in induction of cytosol reduced-NAD(P):menadione oxidoreductase and microsomal aryl hydrocarbon hydroxylase in the mouse. (1977) (84)
Cytosolic receptor for aryl hydrocarbon hydroxylase induction by polycyclic aromatic compounds. Evidence for structural and regulatory variants among established cell cultured lines. (1977) (83)
TCDD decreases ATP levels and increases reactive oxygen production through changes in mitochondrial F(0)F(1)-ATP synthase and ubiquinone. (2006) (83)
Genetic differences in the extent of aryl hydrocarbon hydroxylase induction in mouse fetal cell cultures. (1970) (83)
Pharmacogenomics and “Individualized Drug Therapy” (2003) (82)
Regulatory gene product of the Ah complex. Comparison of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 3-methylcholanthrene binding to several moieties in mouse liver cytosol. (1981) (81)
Cytochrome P450 gene expression and regulation (1985) (80)
P450 gene nomenclature based on evolution. (1991) (80)
Evidence in rat and mouse liver for temporal control of two forms of cytochrome P-450 inducible by 2,3,7,8-tetrachlorodibenzo-p-dioxin. (1978) (80)
Assignment of the human 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible cytochrome P1-450 gene to chromosome 15. (1985) (80)
Aryl hydrocarbon hydroxylase induction in human lymphocyte cultures by 2,3,7,8-tetrachlorodibenzo-p-dioxin. (1974) (79)
Xenobiotic-metabolizing Cytochromes P450 Convert Prostaglandin Endoperoxide to Hydroxyheptadecatrienoic Acid and the Mutagen, Malondialdehyde* (2000) (77)
2,3,7,8-tetrachlorodibenzo-p-dioxin as cocarcinogen causing 3-methylcholanthrene-initiated subcutaneous tumors in mice genetically "nonresponsive" at Ah locus. (1978) (77)
Aryl hydrocarbon hydroxylase induction in mammalian liver cell culture. I. Stimulation of enzyme activity in nonhepatic cells and in hepatic cells by phenobarbital, polycyclic hydrocarbons, and 2,2-bis(p-chlorophenyl)-1,1,1-trichloroethane. (1971) (77)
The role of ribonucleic acid and protein synthesis in microsomal aryl hydrocarbon hydroxylase induction in cell culture. The independence of transcription and translation. (1970) (77)
Pharmacogenomics and "individualized drug therapy": high expectations and disappointing achievements. (2003) (76)
Induction of Aryl Hydrocarbon Hydroxylase Activity in Various Cell Cultures by 2,3,7,8-Tetrachlorodibenzo-p-dioxin (1975) (76)
Uroporphyria produced in mice by iron and 5-aminolaevulinic acid does not occur in Cyp1a2(-/-) null mutant mice. (1998) (75)
4-aminobiphenyl-induced liver and urinary bladder DNA adduct formation in Cyp1a2(-/-) and Cyp1a2(+/+) mice. (2003) (74)
Comparison of the flanking regions and introns of the mouse 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible cytochrome P1-450 and P3-450 genes. (1985) (74)
From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions. (2008) (74)
Human cytochrome P450 (CYP) genes: recommendations for the nomenclature of alleles. (2000) (73)
Tentative identification of benzo[a]pyrene metabolite-nucleoside complexes produced in vitro by mouse liver microsomes. (1978) (73)
CHAPTER 7 – The Ah Receptor: Controlling Factor in the Induction of Drug-Metabolizing Enzymes by Certain Chemical Carcinogens and Other Environmental Pollutants (1983) (73)
Genetic evidence for many unique liver microsomal P-450-mediated monooxygenase activities in heterogeneic stock mice. (1981) (72)
Genetically mediated induction of drug-metabolizing enzymes associated with congenital defects in the mouse. (1977) (72)
Role of cytochrome p4501 family members in the metabolic activation of polycyclic aromatic hydrocarbons in mouse epidermis. (2004) (72)
Human Ah receptor (AHR) gene: localization to 7p15 and suggestive correlation of polymorphism with CYP1A1 inducibility. (1997) (72)
NAD(P)H:menadione oxidoreductase. Novel purification of enzyme cDNA and complete amino acid sequence, and gene regulation. (1986) (72)
Cytochrome P450: evolution and functional diversity. (1994) (71)
How knockout mouse lines will be used to study the role of drug-metabolizing enzymes and their receptors during reproduction and development, and in environmental toxicity, cancer, and oxidative stress. (1997) (71)
Genetic expression of aryl hydrocarbon hydroxylase induction. Presence or absence of association with zoxazolamine, diphenylhydantoin, and hexobarbital metabolism. (1974) (69)
A sensitive radiometric assay of aminopyrine N-demethylation. (1973) (69)
Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily (2011) (68)
Structural gene products of the Ah locus. Evidence for many unique P-450-mediated monooxygenase activities reconstituted from 3-methylcholanthrene-treated C57BL/6N mouse liver microsomes. (1981) (68)
Structural gene product of the [Ah] complex. Evidence for transcriptional control of cytochrome P1-450 induction by use of a cloned DNA sequence. (1981) (68)
Human P3450: cDNA and complete amino acid sequence (1986) (67)
Generation of 'humanized' hCYP1A1_1A2_Cyp1a1/1a2(-/-) mouse line. (2007) (67)
Pharmacogenomics, ethnicity, and susceptibility genes (2001) (67)
Correlation of type I, type II, and reverse type I difference spectra with absolute changes in spin state of hepatic microsomal cytochrome P-450 iron from five mammalian species. (1978) (66)
Basal and inducible CYP1 mRNA quantitation and protein localization throughout the mouse gastrointestinal tract. (2008) (66)
Bioactivation versus detoxication of the urothelial carcinogen aristolochic acid I by human cytochrome P450 1A1 and 1A2. (2012) (65)
Genetic polymorphisms in human drug-metabolizing enzymes: potential uses of reverse genetics to identify genes of toxicological relevance. (1997) (65)
The murine Cyp1a-1 gene negatively regulates its own transcription and that of other members of the aromatic hydrocarbon-responsive [Ah] gene battery. (1990) (63)
Comparison of aryl hydrocarbon hydroxylase and acetanilide 4-hydroxylase induction by polycyclic aromatic compounds in human and mouse cell lines. (1985) (62)
Human aldehyde dehydrogenase genes: alternatively spliced transcriptional variants and their suggested nomenclature (2009) (62)
Characterization of the MTF-1 transcription factor from zebrafish and trout cells. (2000) (62)
Genetic regulation of aryl hydrocarbon hydroxylase induction in the mouse. (1972) (62)
Evolutionary divergence and functions of the human acyl-CoA thioesterase gene (ACOT) family (2010) (62)
Human cytochrome P-450 (CYP) genes: a web page for the nomenclature of alleles. (2001) (62)
Drug metabolic enzymes in developmental toxicology. (1996) (61)
Differential regulation of mouse Ah receptor gene expression in cell lines of different tissue origins. (1996) (61)
Electrofocusing of integral membrane proteins in mixtures of zwitterionic and nonionic detergents. (1979) (60)
Isolation and characterization of full-length mouse cDNA and genomic clones of 3-methylcholanthrene-inducible cytochrome P1-450 and P3-450. (1984) (60)
Inhibition of CYP1A1 enzyme activity in mouse hepatoma cell culture by soybean isoflavones. (1999) (59)
Recommendations for locus‐specific databases and their curation (2008) (59)
Phenotype of the Cyp1a1/1a2/1b1(-/-) Triple-Knockout Mouse (2008) (59)
Genetic differences in susceptibility to chemically induced myelotoxicity and leukemia. (1981) (58)
CYP1A2 is essential in murine uroporphyria caused by hexachlorobenzene and iron. (2000) (58)
Genetic differences in aryl hydrocarbon hydroxylase induction and benzo(a)pyrene-produced tumorigenesis in the mouse. (1973) (58)
Association between DNA variant sites in the apolipoprotein A5 gene and coronary heart disease in Chinese. (2005) (58)
Perturbation of the mitosis/apoptosis balance: a fundamental mechanism in toxicology. (1997) (58)
Lipid metabolism and body composition in Gclm(-/-) mice. (2011) (58)
Interaction between the Ah receptor and proteins binding to the AP-1-like electrophile response element (EpRE) during murine phase II [Ah] battery gene expression. (1995) (57)
Uncoupling-mediated generation of reactive oxygen by halogenated aromatic hydrocarbons in mouse liver microsomes. (2004) (57)
Statistical power of association using the extreme discordant phenotype design (2006) (56)
Drug-Metabolizing Enzymes, Polymorphisms and Interindividual Response to Environmental Toxicants (2000) (56)
Aryl hydrocarbon hydroxylase, epoxide hydrase, and 7,12-dimethylbenz(a)anthracene-produced skin tumorigenesis in the mouse. (1972) (55)
Genetic expression of aryl hydrocarbon hydroxylase activity in the mouse. Distinction between the "responsive" homozygote and heterozygote at the Ah locus. (1975) (55)
The Ah receptor: binding specificity only for foreign chemicals? (1984) (55)
The human dioxin-inducible NAD(P)H: quinone oxidoreductase cDNA-encoded protein expressed in COS-1 cells is identical to diaphorase 4. (1991) (54)
Organ-Specific Roles of CYP1A1 during Detoxication of Dietary Benzo[a]pyrene (2010) (54)
Activation of transcription factors in zebrafish cell cultures by environmental pollutants. (2000) (54)
Aryl hydrocarbon hydroxylase induction in mammalian liver cell culture. 3. Effects of various sera, hormones, biogenic amines, and other endogenous compounds on the enzyme activity. (1972) (53)
Comparison of mouse hepatic mitochondrial versus microsomal cytochromes P450 following TCDD treatment. (2006) (53)
Role of CYP2A5 and 2G1 in acetaminophen metabolism and toxicity in the olfactory mucosa of the Cyp1a2(-/-) mouse. (1998) (53)
“Gene‐Swap Knock‐in” Cassette in Mice to Study Allelic Differences in Human Genes (2000) (53)
Aryl hydrocarbon hydroxylase induction in mammalian liver cell culture. II. Effects of actinomycin D and cycloheximide on induction processes by phenobarbital or polycyclic hydrocarbons. (1971) (53)
Genetic expression of aryl hydrocarbon hydroxylase induction. Genetic specificity resides in the fraction containing cytochromes P448 and P450. (1973) (53)
Isolation and characterization of a cloned DNA sequence associated with the murine Ah locus and a 3-methylcholanthrene-induced form of cytochrome P-450. (1981) (53)
The in vitro metabolism and convalent binding of benzo[a]pyrene to DNA catalysed by trout liver microsomes. (1979) (53)
Genetic association of increases in naphthalene, acetanilide, and biphenyl hydroxylations with inducible aryl hydrocarbon hydroxylase in mice. (1976) (52)
Regulation of mouse cytochrome P3-450 by the Ah receptor. Studies with a P3-450 cDNA clone. (1984) (52)
Effects of cytochrome P1-450 inducers on the cell-surface receptors for epidermal growth factor, phorbol 12,13-dibutyrate, or insulin of cultured mouse hepatoma cells. (1983) (52)
Mouse cytochrome P3-450: complete cDNA and amino acid sequence. (1984) (52)
Structural gene products of the Ah complex. Increases in large mRNA from mouse liver associated with cytochrome P1-450 induction by 3-methylcholanthrene. (1981) (51)
Cyp1a2 protects against reactive oxygen production in mouse liver microsomes. (2004) (51)
Genetic differences in the induction of monooxygenase activities by polycyclic aromatic compounds (1979) (51)
Regulation of [Ah] gene battery enzymes and glutathione levels by 5,10-dihydroindeno[1,2-b]indole in mouse hepatoma cell lines. (1994) (50)
Human cytochromes P 450 in health and disease (2012) (50)
Genetic expression of aryl hydrocarbon hydroxylase induction. VI. Control of other aromatic hydrocarbon-inducible mono-oxygenase activities at or near the same genetic locus. (1973) (50)
Isolation, sequence, and developmental expression of rat UGT2B2: the gene encoding a constitutive UDP glucuronosyltransferase that metabolizes etiocholanolone and androsterone. (1991) (50)
Microsomal Hydroxylase Induction in Liver Cell Culture by Phenobarbital, Polycyclic Hydrocarbons, and p,p'-DDT (1971) (50)
Contributions of the Three CYP1 Monooxygenases to Pro-Inflammatory and Inflammation-Resolution Lipid Mediator Pathways (2013) (49)
Growth signal pathways (1990) (49)
ZIP14 and ZIP8 zinc/bicarbonate symporters in Xenopus oocytes: characterization of metal uptake and inhibition. (2012) (49)
Altered regulation of P-450IA1 expression in a multidrug-resistant MCF-7 human breast cancer cell line. (1988) (49)
For Dioxin-induced Birth Defects, Mouse or Human CYP1A2 in Maternal Liver Protects whereas Mouse CYP1A1 and CYP1B1 Are Inconsequential* (2006) (48)
Developmental and tissue-specific differential regulation of the mouse dioxin-inducible P1-450 and P3-450 genes. (1985) (48)
Dioxin-inducible enhancer region upstream from the mouse P(1)450 gene and interaction with a heterologous SV40 promoter. (1986) (48)
Update on the human and mouse lipocalin (LCN) gene family, including evidence the mouse Mup cluster is result of an “evolutionary bloom” (2019) (47)
The Y-box Motif Mediates Redox-dependent Transcriptional Activation in Mouse Cells (*) (1995) (47)
Analysis of human CYP1A1 and CYP1A2 genes and their shared bidirectional promoter in eight world populations (2010) (47)
SLC39A8 gene encoding a metal ion transporter: discovery and bench to bedside (2019) (47)
Separation of acetanilide and its hydroxylated metabolites and quantitative determination of "acetanilide 4-hydroxylase activity" by high-pressure liquid chromatography. (1979) (46)
Genetic regulation of aryl hydrocarbon hydroxylase induction. V. Specific changes in spin state of cytochrome P 450 from genetically responsive animals. (1973) (46)
Ontogenetic expression of regulatory and structural gene products associated with the Ah locus. Comparison of rat, mouse, rabbit and Sigmoden hispedis. (1980) (45)
In Utero and Lactational Exposure to PCBs in Mice: Adult Offspring Show Altered Learning and Memory Depending on Cyp1a2 and Ahr Genotypes (2011) (45)
Can personalized drug therapy be achieved? A closer look at pharmaco-metabonomics. (2006) (45)
Genetic expression of aryl hydrocarbon hydroxylase induction. 3. Changes in the binding of n-octylamine to cytochrome P-450. (1972) (45)
Oral benzo[a]pyrene‐induced cancer: Two distinct types in different target organs depend on the mouse Cyp1 genotype (2010) (44)
Genetically regulated aryl hydrocarbon hydroxylase induction in the eye: possible significance of the drug-metabolizing enzyme system for the retinal pigmented epithelium-choroid. (1975) (44)
Negative regulation of the murine cytosolic aldehyde dehydrogenase-3 (Aldh-3c) gene by functional CYP1A1 and CYP1A2 proteins. (1992) (44)
Mice deficient in the gene for cytochrome P450 (CYP)1A1 are more susceptible than wild-type to hyperoxic lung injury: evidence for protective role of CYP1A1 against oxidative stress. (2014) (44)
Clinical pharmacology. Possible clinical importance of genetic differences in drug metabolism. (1981) (44)
Enzyme induction by L-buthionine (S,R)-sulfoximine in cultured mouse hepatoma cells. (1995) (43)
21 – The Ah Locus: Genetic Regulation of the Enzymes which Metabolize Polycyclic Hydrocarbons and the Risk for Cancer (1978) (43)
Role of cytochrome P450 1A2 in bilirubin degradation Studies in Cyp1a2 (-/-) mutant mice. (2001) (43)
Markedly increased constitutive CYP1A1 mRNA levels in the fertilized ovum of the mouse. (1998) (43)
Perturbation of the mitosis/apoptosis balance: A fundamental mechanism in toxicology (1997) (42)
Role of P450 1A1 and P450 1A2 in bioactivation versus detoxication of the renal carcinogen aristolochic acid I: studies in Cyp1a1-/-, Cyp1a2-/-, and Cyp1a1/1a2-/- mice. (2011) (42)
P450 genes: evolution, regulation, and relationship to human cancer and pharmacogenetics. (1986) (42)
AN ELECTRON SPIN RESONANCE STUDY OF NEOPLASMS. (1963) (42)
Generation of a Slc39a8 hypomorph mouse: markedly decreased ZIP8 Zn²⁺/(HCO₃⁻)₂ transporter expression. (2011) (41)
Mouse microsomal Class 3 aldehyde dehydrogenase: AHD3 cDNA sequence, inducibility by dioxin and clofibrate, and genetic mapping. (1996) (40)
Differential induction of murine Ah locus-associated monooxygenase activities in rabbit liver and kidney. (1975) (40)
Interaction between the catalytic and modifier subunits of glutamate-cysteine ligase. (2007) (40)
Elevated estrogen 16 alpha-hydroxylase activity: is this a genotoxic or nongenotoxic biomarker in human breast cancer risk? (1993) (40)
Pharmacogenetics: 65 candles on the cake (1997) (40)
Theophylline pharmacokinetics: comparison of Cyp1a1(−/−) and Cyp1a2(−/−) knockout mice, humanized hCYP1A1_1A2 knock-in mice lacking either the mouse Cyp1a1 or Cyp1a2 gene, and Cyp1(+/+) wild-type mice (2005) (39)
Knock-In Mouse Lines Expressing either Mitochondrial or Microsomal CYP1A1: Differing Responses to Dietary Benzo[a]pyrene as Proof of Principle (2009) (39)
Characterization of cytochrome P2-450 (20-S) mRNA. Association with the P1-450 genomic gene and differential response to the inducers 3-methylcholanthrene and isosafrole. (1983) (38)
Marked increases in hepatic NAD(P)H:oxidoreductase gene transcription and mRNA levels correlated with a mouse chromosome 7 deletion. (1989) (38)
Pharmacogenomics: out of the lab and into the community. (2001) (38)
Genetic differences in alcohol drinking preference between inbred strains of mice. (1997) (37)
Pharmacogenetics: an approach to understanding chemical and biologic aspects of cancer. (1980) (37)
Applying new biotechnologies to the study of occupational cancer--a workshop summary. (2004) (37)
Mouse dioxin-inducible cytosolic aldehyde dehydrogenase-3: AHD4 cDNA sequence, genetic mapping, and differences in mRNA levels. (1993) (36)
Cytochrome P450 1A1 (CYP1A1) protects against nonalcoholic fatty liver disease caused by Western diet containing benzo[a]pyrene in mice. (2018) (36)
Human P(3)450: cDNA and complete protein sequence, repetitive Alu sequences in the 3' nontranslated region, and localization of gene to chromosome 15. (1987) (36)
Structural gene products of the murine Ah complex. Differences in ontogenesis and glucosamine incorporation between liver microsomal cytochromes P1-450 and P-448 induced by polycyclic aromatic compounds. (2005) (36)
Quantitation of hepatic cytochrome P1-450 mRNA with the use of a cloned DNA probe. Effects of various P-450 inducers in C57BL/6N and DBA/2N mice. (1982) (35)
Stable expression of mouse Cyp1a1 and human CYP1A2 cDNAs transfected into mouse hepatoma cells lacking detectable P450 enzyme activity. (1990) (35)
Regulation of mouse Ah receptor (Ahr) gene basal expression by members of the Sp family of transcription factors. (1998) (35)
Association of fertility, fitness and longevity with the murine Ah locus among (C57BL/6N) (C3H/HeN) recombinant inbred lines. (1984) (35)
Stimulation of Aryl Hydrocarbon Hydroxylase Induction in Cell Cultures by Interferon (1973) (35)
Cell-specific induction of mouse Cyp1a1 mRNA during development. (1989) (34)
Nomenclature for alleles of the cytochrome P450 oxidoreductase gene. (2009) (34)
Microsomal aryl hydrocarbon hydroxylase in rat adrenal: regulation by ACTH but not by polycyclic hydrocarbons. (1979) (33)
Isosafrole-induced cytochrome P2-450 in DBA/2N mouse liver. Characterization and genetic control of induction. (1984) (33)
Biological effects of the Sudan dyes. Role of the Ah cytosolic receptor. (1983) (33)
Personalized medicine: Genetic risk prediction of drug response (2017) (33)
Further studies on genetically mediated differences in monooxygenase activities and spin state of cytochrome P450 iron from rabbit, rat, and mouse liver. (1973) (33)
Binding of polycyclic aromatic hydrocarbons to DNA: comparison with mutagenesis and tumorigenesis. (1980) (32)
Inter-individual susceptibility to environmental toxicants--a current assessment. (2005) (32)
Aromatic hydrocarbon receptor polymorphism: development of new methods to correlate genotype with phenotype. (1998) (32)
Interaction of the regulatory domains of the murine Cyp1a1 gene with two DNA-binding proteins in addition to the Ah receptor and the Ah receptor nuclear translocator (ARNT). (1994) (31)
Role of Protein Kinase C-mediated Protein Phosphorylation in Mitochondrial Translocation of Mouse CYP1A1, Which Contains a Non-canonical Targeting Signal* (2006) (31)
Genes encoding drug-metabolizing enzymes: possible role in human disease. (1988) (31)
Inducible monooxygenase activities and 3-methyl-cholanthrene-initiated tumorigenesis in mouse recombinant inbred sublines. (1976) (31)
Pyrolysis products from amino acids and protein: highest mutagenicity requires cytochrome P1-450. (1979) (31)
Purification and characterization of a microsomal cytochrome P‐450 with high activity of coumarin 7‐hydroxylase from mouse lives (1984) (30)
Pharmacogenetics in clinical pharmacology and toxicology. (1995) (30)
Localization of cytochrome P1-450 and P3-450 genes to mouse chromosome 9. (1984) (30)
2,3,7,8-Tetrachlorodibenzo-p-dioxin: covalent binding of reactive metabolic intermediates principally to protein in vitro. (1979) (30)
1462V mutation in the human CYP1A1 gene: lack of correlation with either the Msp I 1.9 kb (M2) allele or CYP1A1 inducibility in a three-generation family of east Mediterranean descent. (1994) (29)
Effects of microsomal enzyme inducers in vivo and inhibitors in vitro on the covalent binding of benzo[a]pyrene metabolites to DNA catalyzed by liver microsomes from genetically responsive and nonresponsive mice. (1979) (29)
Mouse lung CYP1A1 catalyzes the metabolic activation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). (2006) (29)
Tissue-Specific Induction of Mouse ZIP8 and ZIP14 Divalent Cation/Bicarbonate Symporters by, and Cytokine Response to, Inflammatory Signals (2014) (29)
Mouse dioxin-inducible NAD(P)H: menadione oxidoreductase: NMO1 cDNA sequence and genetic differences in mRNA levels. (1994) (29)
CYP1A1 and CYP1A2 expression: comparing 'humanized' mouse lines and wild-type mice; comparing human and mouse hepatoma-derived cell lines. (2009) (29)
Update on genome completion and annotations: Protein Information Resource (2004) (29)
Evolution of the P450 gene superfamily. (1988) (28)
Formation of benzo[a]pyrene metabolite-nucleoside adducts in isolated perfused rat and mouse liver and in mouse lung slices. (1979) (28)
NADPH-cytochrome P-450 reductase: preferential inhibition by ellipticine and other type II compounds having little effect on NADPH-cytochrome c reductase. (1980) (28)
Naphthalene toxicity in mice and aryl hydrocarbon receptor-mediated CYPs. (2006) (28)
Improved drug therapy: triangulating phenomics with genomics and metabolomics (2014) (28)
Uroporphyria in mice: Thresholds for hepatic CYP1A2 and iron (2002) (28)
Decreased Hnf-1 gene expression in mice homozygous for a 1.2-centiMorgan deletion on chromosome 7. (1990) (27)
The DNA binding of benzo[alpha]pyrene metabolites catalysed by rat lung microsomes in vitro and in isolated perfused rat lung. (1979) (27)
"Oxidative stress" response in liver of an untreated newborn mouse having a 1.2-centimorgan deletion on chromosome 7. (1992) (27)
Regional linkage analysis of the dioxin-inducible P-450 gene family on mouse chromosome 9. (1985) (27)
Cytochrome P450 (CYP) Gene Superfamily (2011) (27)
Aryl hydrocarbon receptor ligand 2,3,7,8-tetrachlorodibenzo-p-dioxin enhances liver damage in bile duct-ligated mice. (2011) (27)
Possible Role of Cytochromes P450 in Lupus Erythematosus and Related Disorders (1994) (26)
Proposal for an allele nomenclature system based on the evolutionary divergence of haplotypes (2002) (26)
Expression of the mouse P(1)450 gene during differentiation without foreign chemical stimulation. (1987) (26)
Early onset senescence occurs when fibroblasts lack the glutamate-cysteine ligase modifier subunit. (2009) (26)
Identification of genetic differences in drug metabolism: Prediction of individual risk of toxicity or cancer (1991) (26)
Novel P143L polymorphism of the LCAT gene is associated with dyslipidemia in Chinese patients who have coronary atherosclerotic heart disease. (2004) (26)
The AP-1 site and the cAMP- and serum response elements of the c-fos gene are constitutively occupied in vivo. (1991) (25)
Oral N-acetylcysteine rescues lethality of hepatocyte-specific Gclc-knockout mice, providing a model for hepatic cirrhosis. (2010) (25)
Genetic control of carcinogen metabolism leading to individual differences in cancer risk (1978) (25)
Murine mdr-1, mdr-2, and mdr-3 gene expression: no coinduction with the Cyp1a-1 and Nmo-1 genes in liver by 2,3,7,8-tetrachlorodibenzo-p-dioxin. (1991) (25)
The 1986 Bernard B. Brodie award lecture. The genetic regulation of drug-metabolizing enzymes. (1988) (25)
Use of fetal cell culture as an experimental system for predicting drug metabolism in the intact animal (1973) (24)
Genetic differences in phenytoin pharmacokinetics. In vivo clearance and in vitro metabolism among inbred strains of mice. (1980) (24)
Manganese accumulation in the mouse ear following systemic exposure (2008) (24)
Pharmacological rescue of the 14CoS/14CoS mouse: hepatocyte apoptosis is likely caused by endogenous oxidative stress. (2003) (24)
Fate of inducer during induction of aryl hydrocarbon hydroxylase activity in mammalian cell culture. I. Intracellular entry, binding, distribution, and metabolism. (1970) (24)
Effects of environmental chemicals on the genetic regulation of microsomal enzyme systems (1977) (24)
Aryl hydrocarbon hydroxylase induction in mammalian liver-derived cell cultures. Effects of various metabolic inhibitors on the enzyme activity in hepatoma cells. (1976) (24)
Decrease in 4-aminobiphenyl-induced methemoglobinemia in Cyp1a2(-/-) knockout mice. (2002) (24)
Expression of aryl hydrocarbon hydroxylase induction and suppression of tyrosine aminotransferase induction in somatic-cell hybrids. (1972) (23)
NAD(P)H:quinone oxidoreductase expression in Cyp1a-knockout and CYP1A-humanized mouse lines and its effect on bioactivation of the carcinogen aristolochic acid I. (2012) (23)
Genetic architecture of susceptibility to PCB126-induced developmental cardiotoxicity in zebrafish. (2011) (23)
Glutathione-deficient mice are susceptible to TCDD-Induced hepatocellular toxicity but resistant to steatosis. (2012) (23)
Response of [Ah] battery genes to compounds that protect against menadione toxicity. (1995) (23)
Protective role of cytochrome P450 1A1 (CYP1A1) against benzo[a]pyrene-induced toxicity in mouse aorta. (2014) (23)
Mitochondrial targeting of mouse NQO1 and CYP1B1 proteins. (2013) (22)
Genetic risk prediction: individualized variability in susceptibility to toxicants. (2013) (22)
Similarities between mouse and rat-liver microsomal cytochromes P-450 induced by 3-methylcholanthrene. Evidence from catalytic, immunologic, and recombinant DNA studies. (1982) (22)
Spectral evidence for weak ligand in sixth position of hepatic microsomal cytochrome P-450 low spin ferric iron in vivo. (1978) (22)
P450 genes and evolutionary genetics. (1987) (22)
Hyperfine Structure in the EPR Spectrum of the Manganous Ion in Frozen Solutions (1964) (22)
Pharmacogenetics: a possible pragmatic perspective in neoplasm predictability. (1978) (21)
Genetic differences in drug metabolism associated with ocular toxicity. (1982) (21)
Comparing gene expression during cadmium uptake and distribution: untreated versus oral Cd-treated wild-type and ZIP14 knockout mice. (2015) (21)
Cytochrome P1-450 structural gene in mouse, rat, and rabbit: differences in DNA methylation and developmental expression of mRNA. (1982) (20)
Menadione toxicity in two mouse liver established cell lines having striking genetic differences in quinone reductase activity and glutathione concentrations. (1993) (20)
Generation of a 'humanized' hCYP1A1_1A2_Cyp1a1/1a2(-/-)_Ahrd mouse line harboring the poor-affinity aryl hydrocarbon receptor. (2008) (20)
Trout CYP1A3 Gene: Recognition of Fish DNA Motifs by Mouse Regulatory Proteins (1999) (20)
Cellular Responses To Oxidative Stress (1990) (19)
cDNA and complete amino acid sequence of mouse P2(450): allelic variant of mouse P3(450) gene. (1986) (19)
Structure of the mouse cytochrome P1-450 genomic gene. (1983) (19)
In utero and lactational exposure to a complex mixture of polychlorinated biphenyls: toxicity in pups dependent on the Cyp1a2 and Ahr genotypes. (2011) (19)
Oral Cadmium in Mice Carrying 5 Versus 2 Copies of the Slc39a8 Gene (2014) (19)
CYTOCHROME P450 KNOCKOUT MICE: NEW TOXICOLOGICAL MODELS (1998) (19)
Aryl hydrocarbon hydroxylase induction by benzo[a]anthracene: regulatory gene localized to the distal portion of mouse chromosome 17. (1984) (19)
Genetic aspects of toxicity during development. (1976) (19)
Tyrphostin [correction of Tryphostin] AG879, a tyrosine kinase inhibitor: prevention of transcriptional activation of the electrophile and the aromatic hydrocarbon response elements. (2001) (19)
Subcellular events occurring during aryl hydrocarbon hydroxylase induction: no requirement for metabolism of polycyclic hydrocarbon inducer. (1977) (19)
A novel allele in the promoter of the hepatic lipase is associated with increased concentration of HDL-C and decreased promoter activity DOI 10.1194/jlr.M200046-JLR200 (2002) (18)
Effect of chronic glutathione deficiency on the behavioral phenotype of Gclm-/- knockout mice. (2012) (18)
Zinc- and bicarbonate-dependent ZIP8 transporter mediates selenite uptake (2016) (18)
7H-dibenzo[c,g]carbazole metabolism by the mouse and human CYP1 family of enzymes. (2007) (18)
Genetic Differences in Benzo[a]pyrene Carcinogenic Index in Vivo and in Mouse Cytochrome P1 450-Mediated Benzo[a]pyrene Metabolite Binding to DNA in Vitro (1977) (18)
Ecogenetics: From Ecology To Health (1997) (17)
Chapter 3 – Human Genetic Variation in the Enzymes of Detoxication (1980) (17)
The Ah locus: aromatic hydrocarbon responsiveness... of mice and men. (1978) (17)
Aryl hydrocarbon hydroxylase inducibility among primary relatives of children with leukemia or solid tumors. (1984) (17)
Hepatic ZIP8 deficiency is associated with disrupted selenium homeostasis, liver pathology, and tumor formation. (2018) (17)
Comparison of gene expression in cell culture to that in the intact animal: relevance to drugs and environmental toxicants. Focus on "development of a transactivator in hepatoma cells that allows expression of phase I, phase II, and chemical defense genes". (2006) (17)
Multiple forms of inducible drug-metabolizing enzymes: A reasonable mechanism by which any organism can cope with adversity (1979) (17)
Genetics and functions of the retinoic acid pathway, with special emphasis on the eye (2019) (17)
Transcriptional derepression of the murine Cyp1a‐1 gene by mevinolin (1992) (16)
Characterization of a cDNA clone for mouse phenobarbital-inducible cytochrome P-450b. (1984) (16)
Retrovirally expressed metal response element-binding transcription factor-1 normalizes metallothionein-1 gene expression and protects cells against zinc, but not cadmium, toxicity. (2002) (16)
Carcinogenic benzo(a)pyrene metabolites bound to DNA: metabolic formation by human cultured lymphocytes and by human liver microsomes. (1978) (15)
Association of the Ah locus with specific changes in metyrapone and ethylisocyanide binding to mouse liver microsomes. (1976) (15)
Fate of inducer during induction of aryl hydrocarbon hydroxylase activity in mammalian cell culture. II. Levels of intracellular polycyclic hydrocarbon during enzyme induction and decay. (1970) (15)
Drug metabolism and signal transduction: possible role of Ah receptor and arachidonic acid cascade in protection from ethanol toxicity. (1994) (15)
Sensitivity of CYP1A1 mRNA inducibility by dioxin is the same in Cyp1a2(+/+) wild-type and Cyp1a2(-/-) null mutant mice. (1997) (15)
Genetic differences in metabolism of polycyclic aromatic carcinogens and aromatic amines by mouse liver microsomes. Detection by DNA binding of metabolites and by mutagenicity in histidine-dependent Salmonella typhimurium in vitro. (1979) (14)
Overview of PAX gene family: analysis of human tissue-specific variant expression and involvement in human disease (2020) (14)
DNA Binding of Benzo[a]pyrene Metabolites (1980) (14)
In utero gene expression in the Slc39a8(neo/neo) knockdown mouse (2018) (14)
Uroporphyria and hepatic carcinogenesis induced by polychlorinated biphenyls-iron interaction: absence in the Cyp1a2(-/-) knockout mouse. (2005) (13)
Update on human genome completion and annotations: Gene nomenclature (2003) (13)
A MICROSOMAL DIFFERENCE BETWEEN NORMAL LIVER AND "MINIMAL-DEVIATION" HEPATOMA 5123 DETECTABLE BY ELECTRON SPIN RESONANCE. (1964) (13)
Birth defects and aplastic anemia: differences in polycyclic hydrocarbon toxicity associated with the Ah locus (1977) (13)
Comparative EPR study on high-spin ferric porphine complexes and cytochrome P-450 having rhombic character. (1977) (13)
THE MURINE Ah LOCUS AND DYSMORPHOGENESIS (1977) (13)
Inbreeding and epigenetics: beneficial as well as deleterious effects (2010) (13)
Genetic differences in the metabolism of carcinogens and in the binding of benzo (a) pyrene metabolites to DNA. (1976) (13)
Mouse lung CYP 1 A 1 catalyzes the metabolic activation of 2-amino-1-methyl-6-phenylimidazo [ 4 , 5b ] pyridine ( PhIP ) (2007) (12)
Two RFLPs associated with the human P1450 gene linked to the MPI locus on chromosome 15 [HGM8 D15S8]. (1986) (12)
Selective mouse breeding for short ethanol sleep time has led to high levels of hepatic aromatic hydrocarbon (Ah) receptor. (1989) (12)
Microsomal cytochromes b5 and P450 during induction of aryl hydrocarbon hydroxylase activity in mammalian cell culture. (1970) (12)
The murine aromatic hydrocarbon responsiveness locus: a comparison of receptor levels and several inducible enzyme activities among recombinant inbred lines. (1986) (12)
Genetic differences in cytochrome P-450 during induction of mono-oxygenase activities. (1973) (12)
A structured simple form for ordering genetic tests is needed to ensure coupling of clinical detail (phenotype) with DNA variants (genotype) to ensure utility in publication and databases (2007) (12)
Comparison of oxidative stress response parameters in newborn mouse liver versus simian virus 40 (SV40)-transformed hepatocyte cell lines. (2000) (12)
Human P3(450): cDNA and complete amino acid sequence. (1986) (12)
Localization of UDP glucuronosyltransferase gene(s) on mouse chromosome 5 (1987) (12)
Olfactory Receptor Gene Polymorphisms and Nonallergic Vasomotor Rhinitis (2008) (12)
Uroporphyrin accumulation in hepatoma cells expressing human or mouse CYP1A2: relation to the role of CYP1A2 in human porphyria cutanea tarda. (2003) (11)
Polymorphism of human CYP2D genes involved in drug metabolism: possible relationship to individual cancer risk. (1991) (11)
Evolution of the P450 gene superfamily and regulation of the murine Cyp1a1 gene. (1990) (11)
Possible effect of neonatal polybrominated biphenyl exposure on the developmental abilities of children. (1983) (11)
ASSOCIATION ON TYPE I, TYPE II, AND REVERSE TYPE I DIFFERENCE SPECTRA WITH ABSOLUTE SPIN STATE OF CYTOCHROME P-450 IRON (1977) (11)
Dibenz[a,h]anthracene-induced subcutaneous tumors in mice. Strain sensitivity and the role of carcinogen metabolism. (1983) (11)
Multiple forms of inducible drug-metabolizing enzymes: A reasonable mechanism by which any organism can cope with adversity (2004) (11)
Oral benzo[a]pyrene in Cyp1a1/1b1(–/–) double‐knockout mice: Microarray analysis during squamous cell carcinoma formation in preputial gland duct (2013) (11)
Coffee, myocardial infarction, and CYP nomenclature. (2006) (10)
Benzo[a]pyrene metabolism in mouse liver. Association of both 7,8-epoxidation and covalent binding of a metabolite of the 7,8-diol with the Ah locus. (1985) (10)
Single-nucleotide polymorphisms in the lipoprotein lipase gene associated with coronary heart disease in Chinese. (2002) (10)
Given the complexity of the human genome, can 'personalised medicine' or 'individualised drug therapy' ever be achieved? (2009) (10)
Human Cytochrome P-450 (CYP) Genes (2001) (10)
Update of the keratin gene family: evolution, tissue-specific expression patterns, and relevance to clinical disorders (2022) (10)
Mouse class 3 aldehyde dehydrogenases: positive and negative regulation of gene expression. (1993) (10)
Genetic differences in lethality of newborn mice treated in utero with coplanar versus non-coplanar hexabromobiphenyl. (2006) (10)
Subcellular localization of membrane-bound aryl-hydrocarbon hydroxylase and NAD(P)H-dependent reductase activities in mouse liver. (1980) (9)
Variations in Aryl Hydrocarbon Hydroxylase Activities in Mitogen-Activated Human and Nonhuman Primate Lymphocytes (1984) (9)
A single gene difference in early death caused by hypoplastic anemia in mice receiving oral benzo[a]pyrene daily (1975) (9)
Phospholipase A2 activation and increases in specific prostaglandins in the oxidatively stressed 14CoS/14CoS mouse hepatocyte line. (1998) (9)
Methylation differences in the murine P1450 and P3450 genes in wild-type and mutant hepatoma cell culture. (1986) (9)
Genetic control of drug metabolism: relationship to birth defects. (1982) (8)
Dioxin-induced birth defects : mouse or human CYP 1 A 2 in maternal liver protects , whereas mouse CYP 1 A 1 and CYP 1 B 1 are inconsequential (2006) (8)
A new home for Human Genomics (2012) (8)
Mouse class 3 aldehyde dehydrogenases. (1995) (8)
Changes in aryl hydrocarbon hydroxylase activity and microsomal P450 during polycyclic hydrocarbon treatment of mammalian cells in culture. (1969) (8)
Induction of immunotoxicity by polycyclic hydrocarbons: Role of the Ah locus (1984) (8)
DRUGS AND MICROSOMAL ENZYME FORMATION IN VIVO AND IN MAMMALIAN CELL CULTURE (1969) (8)
Balancer-Cre transgenic mouse germ cells direct the incomplete resolution of a tri-loxP-targeted Cyp1a1 allele, producing a conditional knockout allele. (2003) (7)
An investigation of genetic variation within a series of congenic strains of mice (1984) (7)
Relative roles of CYP2E1 and CYP1A2 in mouse uroporphyria caused by acetone. (2000) (7)
Cyclophilin nomenclature problems, or, 'a visit from the sequence police' (2004) (7)
Expression of the chloramphenicol acetyltransferase (CAT) reporter gene by the murine Cyp1a-2 (cytochrome P3(450)) promoter in hepatoma cell cultures. (1990) (7)
Aryl hydrocarbon hydroxylase induction in cell culture as a function of gene expression. (1971) (7)
Update on human genome completion and annotations: Protein information resource (2004) (6)
Circular dichroism studies on the binding of type I substrates and reverse type I compounds to rabbit liver microsomal cytochrome P-450. (1978) (6)
Aryl Hydrocarbon Hydroxylase Activity “Of Mice and Humans” (1983) (6)
Association between susceptibility to dibenzanthracene‐induced fibrosarcoma formation and the Ah locus (1983) (6)
The Ah locus. A gene with possible importance in cancer predictability. (1980) (6)
Use of reporter genes and vertebrate DNA motifs in transgenic zebrafish as sentinels for assessing aquatic pollution. (2002) (6)
An example of P-450 catalytic activities not correlated with corresponding P-450 mRNA concentrations. (1986) (6)
Pharmacogenetics and Pharmacogenomics (2006) (5)
Genetic control of drug metabolism. (1978) (5)
Lack of response of the rat liver "class 3" cytosolic aldehyde dehydrogenase to toxic chemicals, glutathione depletion, and other forms of stress. (1994) (5)
Update of the human and mouse Fanconi anemia genes (2015) (5)
Drug metabolism. Growth signal pathways. (1990) (5)
Current cellular assays for measuring clinical drug metabolizing capacity--impact of new molecular biologic techniques. (1986) (5)
Hypoproteinemia and cystic fibrosis. (1966) (5)
Developmental pharmacology and the Ah locus: regulatory and temporal genes affecting teratogenesis. (1979) (5)
Genetic Differences in Enzymes which Metabolize Drugs, Chemical Carcinogens, and Other Environmental Pollutants (1983) (5)
Aldehyde dehydrogenase (ALDH) superfamily in plants: gene nomenclature and comparative genomics (2012) (5)
Purification and characterization of a microsomal cytochrome P-450 with high activity of coumarin 7-hydroxylase from mouse liver. (1984) (5)
Corrigendum to “Advances in pharmacogenomics and individualized drug therapy: exciting challenges that lie ahead” [Eur. J. Pharmacol. 500 (2004) 267–280] (2005) (4)
Structural gene products of the murine ah locus: immunochemical evidence for two forms of liver p-450 induced by 3-methylcholanthrene. Abstr. (1979) (4)
Role of molecular biology in risk assessment. (1996) (4)
Environmental and genetic factors influencing drug metabolism and toxicity (1984) (4)
Pharmacogenetics and human cancer. (1982) (4)
SYMPOSIUM OVERVIEW Drug Metabolic Enzymes in Developmental Toxicology1 (1996) (4)
Head-and-neck squamous cell carcinoma risk in smokers: no association detected between phenotype and AHR, CYP1A1, CYP1A2, or CYP1B1 genotype (2016) (4)
The truth about mouse, human, worms and yeast (2004) (4)
Expression of benz[a]anthracene-inducible aryl hydrocarbon hydroxylase activity in mouse-hamster and mouse-human somatic-cell hybrids. (1972) (4)
Human drug metabolism polymorphisms: use of recombinant DNA techniques. (1987) (4)
Environmental factors influencing the hyperfine structure of manganous low-temperature electron paramagnetic resonance spectra. (1966) (4)
Genetic Differences in Drug Metabolism: Proposed Relationship to Human Birth Defects (1983) (4)
Comparison of the mouse P(1)450 gene and flanking sequences from a MOPC 41 plasmacytoma and normal liver. (1985) (4)
Extrahepatic expression of NAD(P)H:menadione oxidoreductase, UDP glucuronosyltransferase-1A6, microsomal aldehyde dehydrogenase, and hepatic nuclear factor-1 alpha mRNAs in ch/ch and 14CoS/14CoS mice. (1997) (4)
Networking nomenclature (1998) (4)
Measurements of the cytosolic Ah receptor among four strains of Drosophila melanogaster (1985) (3)
Role of host susceptibility to toxicity and cancer caused by pesticides: Cytochromes P450 (2005) (3)
P450 genes and their regulation (1985) (3)
Ornithine decarboxylase induction in liver- and hepatoma-derived cell cultures: no detectable differences between control and 3-methylcholanthrene-treated cells. (1981) (3)
What do animal experiments tell us that in vitro systems cannot? The Human Toxome Project. (2016) (3)
Ligands of four receptors in the nuclear steroid/thyroid hormone superfamily inhibit induction of rat cytosolic aldehyde dehydrogenase-3 (ALDH3c) by 3-methylcholanthrene. (1995) (3)
Analysis and update of the human aldehyde dehydrogenase ( ALDH )g ene (2005) (3)
Covalent binding of diethylstilbestrol to dna catalyzed by hepatic and uterine microsomes. Abstr. (1979) (3)
Aryl hydrocarcon hydroxylase and tyrosine aminotransferase activities in somatic-cell hybrids derived from hepatoma tissue culture HTC (rat) cells and 3T3 (mouse) benzo(a)pyrene-resistant cells. (1974) (3)
Perceptions of genetic research in three rural Appalachian Ohio communities (2012) (3)
Reply to the letter of doctors Shepard and Fantel (1980) (3)
Coffee, myocardial infarction, and CYP nomenclature. Authors' reply (2006) (3)
Hepatic Drug-Metabolizing Enzymes during Embryonic and Fetal Development (1983) (3)
Aryl Hydrocarbon Hydroxylase. Evidence of Receptors for Induction Process in Cell Culture (1979) (2)
COVID-19 vulnerability: the potential impact of genetic susceptibility and airborne transmission (2020) (2)
Drug Metabolism: Evolution (2006) (2)
Localization of the murine Hmg1 gene, encoding an HMG-box protein, to mouse Chromosome 2 (2004) (2)
Cloning genes that encode inducible forms of P-450. (1984) (2)
Identification of genetic differences in debrisoquine hydroxylase activity (1992) (2)
Hemopexin and aryl hydrocarbon hydroxylase induction in the mouse and in cell culture. (1978) (2)
Ecogenetics: genetic susceptibility to environmental adversity (2002) (2)
Designer Genes: A new Era in the Evolution of Man (2011) (2)
Placing human gene families into their evolutionary context (2022) (2)
Birth defects and the potential role of genetic differences in drug metabolism. (1981) (2)
STRUCTURAL GENE PRODUCTS OF THE MURINE Ah LOCUS. IMMUNOCHEMICAL CHARACTERIZATION OF TWO FORMS OF P-450 INDUCED BY POLYCYCLIC AROMATIC COMPOUNDS (1980) (2)
Changes in cytochrome P-450 iron spin state as a function of castration, testosterone or estrogen treatment, vigorous exercise, or starvation. (1984) (2)
The importance of genetics in the metabolism and fate of mutagens and promutagens (1982) (2)
Conflicts of Interests: Declarations for All (2004) (2)
Update of the human and mouse SERPINgene superfamily (2013) (2)
Pharmacogenetics, Wendell W. Weber (Ed.). Oxford University Press, New York (1997), 344, $60.00. (1997) (2)
Effects of cimetidine on theophylline, acetaminophen, and zoxazolamine toxicity in the intact mouse. (1984) (2)
Cloning genes that encode drug-metabolizing enzymes: developmental pharmacology and teratology. (1983) (2)
Improved drug therapy: triangulating phenomics with genomics and metabolomics (2014) (1)
Reply to Kalow et al (2001) (1)
Networking nomenclature [news] (1998) (1)
22LA-03-2 Environmental Susceptibility Genes That Cause Toxicity and Cancer (1999) (1)
Corrigendum to "Personalized medicine: Genetic risk prediction of drug response" [Pharmacol. Ther. 175 (2017) 75-90.]. (2018) (1)
IMPACT OF GENETICS AND GENETIC MONITORING ON PHARMACOLOGY STUDIES (1983) (1)
A Case in Which a Second Gastrointestinal Lesion Was Masked by a Gastrostomy (1966) (1)
Letter to the editor for “Update of the human and mouse Fanconi anemia genes” (2016) (1)
Drugs and the MousePharmacology, Pharmacogenetics, and Pharmacogenomics (2007) (1)
Odorant receptor polymorphisms in patients with non-allergic vasomotor rhinitis☆ (2004) (1)
Mouse Dioxin-Inducible Ahd4 Gene (1996) (1)
Expression, Function and Regulation of Mouse Cytochrome P450 Enzymes: Comparison With Human Cytochrome P450 Enzymes (2010) (1)
Mouse dioxin-inducible Ahd4 gene. Structure of the 5' flanking region and transcriptional regulation. (1997) (1)
The murine Ah locus: genetic differences in birth defects among individuals in the same uterus. (1980) (1)
DNA binding of benzo[a]pyrene metabolites. Effects of substrate and microsomal protein concentration in vitro, dietary contaminants, and tissue differences. (1980) (1)
Thoughts and Speculation about the Role of Arsenic in Toxicity and Cancer IN (1)
Perceptions of genetic research in three rural Appalachian Ohio communities (2012) (0)
Subject Index, Vol. 18, 1979 (1979) (0)
Behavioral phenotyping of two mouse lines with reduced antioxidant capacity (2012) (0)
Mouse cytochrome P3450: complete cDNA and amino acid sequence (0)
Chapter 2 The P450 Gene Superfamily (1990) (0)
Regulation ofMouseCYPIAJGeneExpression byDioxin: Requirement ofTwocis-Acting Elements during Induction (1989) (0)
Genetics and functions of the retinoic acid pathway, with special emphasis on the eye (2019) (0)
Motion: “Omics are of Value in Safety Evaluation” (2006) (0)
913 – EVIDENCE FOR DE NOVO SYNTHESIS OF CYTOCHROME P-448 IN THE “AROMATIC HYDROCARBON RESPONSIVE” MOUSE (1977) (0)
1076 – GENETIC REGULATION OF ARYL HYDROCARBON HYDROXYLASE INDUCTION BY CHEMICAL CARCINOGENS AND OTHER ENVIRONMENTAL POLLUTANTS (1978) (0)
The zinc transporter SLC39A8 is a novel negative feedback regulator of the NF-{kappa}B pathway and innate immune activation (2011) (0)
Update on the human and mouse lipocalin (LCN) gene family, including evidence the mouse Mup cluster is result of an “evolutionary bloom” (2019) (0)
Ecogenetics: The Study of Gene–Environment Interactions (2001) (0)
Autoregulation plus negative and positive control of murine Cyp1a-1 gene expression and the [Ah]battery (1992) (0)
Fatal Epileptic Seizures in Mice Having Compromised Glutathione and Ascorbic Acid Biosynthesis (2023) (0)
Abstracts (2002) (0)
Genetic differences in theophylline (THEO) toxicity associated with the Ah locus: Effects of cimetidine in vitro and in vivo (1982) (0)
The zinc transporter SLC39A8 is a novel negative feedback regulator of the NF-κB pathway and innate immune activation (116.33) (2011) (0)
Genetic Dissection of Complex Traits : Susceptibility to Environmental Agents IN THIS ISSUE (2000) (0)
Cytochrome p1-450 induction involves transcriptional control: proof with the use of a cloned dna probe. Abstr. (1981) (0)
The Environment , Genes , and Asthma (2000) (0)
A new home for Human Genomics (2012) (0)
Why are keratins important? (2022) (0)
SNP‐chips versus CNV patterns: Thinking outside the box (2009) (0)
Head-and-neck squamous cell carcinoma risk in smokers: no association detected between phenotype and AHR, CYP1A1, CYP1A2, or CYP1B1 genotype (2016) (0)
Update of the keratin gene family: evolution, tissue-specific expression patterns, and relevance to clinical disorders (2022) (0)
Cypla2(-/-) null mutant mice develop normally but show deficient drug metabolism (cytochrome P450/embryonic stem cells/arylamine carcinogenesis) (2005) (0)
CONTENTS (2006) (0)
Preservation of the negative image of tooth enamel with dental impression material enhances morphometric measurements of gingival overgrowth (2003) (0)
Personalized medicine: Advantages and shortcomings of genomics versus metabonomics (2008) (0)
Association of the ah locus in the mouse with induction of four microsomal enzyme activities by aromatic hydrocarbon. Abstr (1973) (0)
Differential neurobehavioral responses in PCB-treated mice having different Ahr and Cyp1a2 alleles (2009) (0)
Why are keratins important? (2022) (0)
Inducible aryl hydrocarbon hydroxylase and 7, 12-dimethylbenz(a)- anthracene-produced skin tumorigenesis in the mouse. Abstr. (1972) (0)
Analysis of Constitutive and TCDD-Inducible Expression of Genes in the [Ah] Battery (1991) (0)
Assignment of dioxin-inducible cytochrome P-450 gene family to Chinese hamster chromosome 4 (1985) (0)
Letter to the editor for “Update of the human and mouse Fanconi anemia genes” (2016) (0)
Mammalian GenesCoordinately Regulated byGrowthArrest Signals andDNA-Damaging Agents (1989) (0)
Differences in Patient Response to Psychotropic Drugs (1999) (0)
The metabolism of dibenz(a,h)anthracene (dba) by mouse hepatic microcomses and its relationship to dba-induced tumor formation. Abstr. (1982) (0)
Erratum to: Perceptions of genetic research in three rural Appalachian Ohio communities (2012) (0)
823 – THE Ah LOCUS: REGULATORY AND TEMPORAL GENES AFFECTING DRUG TOXICITY AND TERATOGENESIS (1978) (0)
In utero gene expression in the Slc39a8(neo/neo) knockdown mouse (2018) (0)
Contents, Vol. 18, 1979 (1979) (0)
733 – THE BINDING OF BENZO (A) PYRENE TO DNA CATALYZED BY LUNG MICROSOMES IN VITRO AND IN ISOLATED PERFUSED LUNG (1978) (0)
Genetic differences in carcinogenic index of benzo[a] pyrene in vivo and binding of its metabolites to dna in vitro. Abstr. (1976) (0)
Effect of vitamin C deficiency during postnatal development on adult behavior: functional phenotype of Gulo(–/–) knockout mice (2012) (0)
ベンゾ［a］ピレンの代謝活性化におけるCYP1ファミリーの役割 (2005) (0)
Pyrolysis products from amino acids and protein : Highest mutagenicity requires cytochrome P 1450 ( environmental mutagenesis / chemical carcinogenesis / cigarette smoking / cytochrome P 450-mediated monooxygenase / metabolic activation ) (0)
An electron spin resonance study of normal and neoplastic biological material (1964) (0)
Screening of 16 common therapeutic drugs. Possible association with the Ah locus. (1983) (0)
A single-gene difference associated with theophylline toxicity in mice (1979) (0)
Cytosolic receptor for ah locus. Evidence for regulatory gene dysfunction in nonresponsive cell cultures containing the receptor. Abstr. (1977) (0)
List of Contributors (2019) (0)
373 CONTENT AND ORGANIZATION OF SPERMATOZOAN DNA (1981) (0)
A Tribute to Elliot S. Vesell (1933–2018) (2018) (0)
Transcriptional start site in the mouse Cyp1a1 (cytochrome P1450) gene. (1989) (0)
14 – PRIMARY LIVER, HEPATOMA, AND LYMPHOCYTE CULTURES USED AS MODELS FOR STUDYING GENETIC REGULATION OF DRUG METABOLISM (1977) (0)

This paper list is powered by the following services:

Other Resources About Daniel W. Nebert

en.wikipedia.org

What Schools Are Affiliated With Daniel W. Nebert?

Daniel W. Nebert is affiliated with the following schools:

Image Attributions

Image Source for Daniel W. Nebert